Completed OBSERVATIONAL NCT00186940

Rasburicase Treatment for Chemotherapy or Malignancy-Induced Hyperuricemia in Asthma/Allergy Patients

A Study of Rasburicase Treatment for Chemotherapy of Malignancy-Induced Hyperuricemia in Patients With a History of Asthma Allergies

Sponsor: Sanofi

Conditions Hyperuricemia Leukemia Lymphoma Tumor Lysis Syndrome

Interventions Rasburicase

Updated 9 times since 2017 Last updated: Apr 24, 2017 Started: Mar 31, 2005 Primary completion: Feb 28, 2010 Completion: Feb 28, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Hyperuricemia and Leukemia, this trial is completed. The trial is conducted by Sanofi and has accumulated 9 data snapshots since 2005. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

9 versions recorded

Jan 2026 — Present [monthly]

Completed
Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed

▶ Show 4 earlier versions

Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None
May 2017 — Apr 2018 [monthly]

Completed NA

Phase: PHASE4 → NA
Feb 2017 — May 2017 [monthly]

Completed PHASE4
Jan 2017 — Feb 2017 [monthly]

Completed PHASE4

First recorded

Mar 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Sanofi
St. Jude Children's Research Hospital

Data source: St. Jude Children's Research Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Boston, United States , Detroit, United States , Fort Worth, United States , Houston, United States , Indianapolis, United States , Memphis, United States , Milwaukee, United States , New York, United States , Palo Alto, United States , Providence, United States and 1 more location